Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Shaan Sudhakaran

Pain Medicine Silver Spring, MD Medical Doctor

NPI 1598101859 CMS profile 1393088

8455 Colesville Rd Ste 200, Silver Spring, MD 20910

Open in the dashboard

General payments

$3,329

102 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Shaan Sudhakaran of Silver Spring, MD is reported in the CMS Open Payments database as having received $3,329 across 102 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 57th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $50 3
2021 General $500 25
2020 General $443 23
2019 General $2,337 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shaan Sudhakaran
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Shaan Sudhakaran were reported at $0. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Shaan Sudhakaran Pain Medicine median Middle half National median
2019 $2,337 $498 $126–$1,682 $163
2020 $443 $284 $80–$910 $114
2021 $500 $399 $112–$1,219 $132
2022 $50 $455 $137–$1,484 $149
2023 $0 $484 $128–$1,495 $160
2024 $0 $498 $131–$1,540 $164
2025 $0 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Medtronic USA, Inc. $1,298 18 payments
  2. Abbott Laboratories $698 16 payments
  3. Collegium Pharmaceutical, Inc. $188 9 payments
  4. Biodelivery Sciences International, Inc. $167 11 payments
  5. Boston Scientific Corporation $145 7 payments
  6. Scilex Pharmaceuticals Inc. $132 8 payments
  7. Horizon Therapeutics plc $122 8 payments
  8. Stimwave Technologies Incorporated $101 1 payment
  9. Pfizer Inc. $90 5 payments
  10. Flexion Therapeutics, Inc. $59 1 payment
  11. Other $329 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $2,637 98 payments
  2. Travel and Lodging $680 3 payments
  3. Education $12 1 payment
Products named General payments · program years 2019–2022
  1. INTELLIS $1,152 12 payments
  2. Proclaim Family of SCS IPGs $619 11 payments
  3. XTAMPZA $188 9 payments
  4. ZTLido $120 7 payments
  5. MYSTIM $108 3 payments
  6. StimQ Freedom 8A Receiver Kit Channel A US w Receiver $101 1 payment
  7. Freedom 8A Receiver Kit Channel A US w Receiver $101 1 payment
  8. StimQ Receiver Stimulator Kit Channel A US w Receiver $101 1 payment
  9. Freedom 4A Receiver Kit Channel A US w Receiver $101 1 payment
  10. StimQ Freedom 4A Receiver Kit Channel A US Receiver $101 1 payment
  11. Other $1,349 76 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

102 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record